The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

When Chicago founder Terry Kath accidentally killed himself, the world was robbed of one of its greatest guitarists ...

Get your monthly fix of all things music, with issues filled with news,reviews,interviews and more ...

From taxes to Trump, here are five things we’re watching for as Council returns Thursday for the first meeting of its spring ...

Netflix documentary Fights, Camera, Action spotlights the show's former producers and their desperate attempts to raise the ...

In a three-hour committee meeting on Wednesday, senators on the Health and Provider Services Committee revived some ...